Home › Funds › Evolutionary Tree Capital Management, LLC › ARWR

Evolutionary Tree Capital Management, LLC position in ARWR

ARROWHEAD PHARMACEUTICALS IN · Health Care

Evolutionary Tree Capital Management, LLC reported holding 19,142 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 2.32% of its reported portfolio and ranking #21 among its reported holdings. Evolutionary Tree Capital Management, LLC has disclosed ARWR holdings in 5 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)19.14K sh
Reported value held$1.25M
Portfolio Weight2.32%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Evolutionary Tree Capital Management, LLC's ARWR position evolved

Evolutionary Tree Capital Management, LLC first disclosed a stake in ARWR in Q3 2023 at 51,266 shares (US$1.4M). The position peaked in Q4 2023 at 51,687 shares, worth US$1.6M. Across 5 filings, Evolutionary Tree Capital Management, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 19,142 shares valued at US$1.3M — an increase of 4,774 shares quarter over quarter.. Notable position changes include a 33% increase in Q3 2026 (shares fell 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 51.27K $1.38M New
Q4 2023 51.69K $1.58M Add
Q1 2024 44.90K $1.28M Reduce
Q2 2026 14.37K $1.17M New
Q3 2026 19.14K $1.25M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ARWR and 13F data

ARWR (ARROWHEAD PHARMACEUTICALS IN) is a Health Care company. 43 other funds we track also report a position in ARWR — the largest reported positions include Avoro Capital Advisors LLC (US$925.6M), FRED ALGER MANAGEMENT, LLC (US$269.1M), BAKER BROS. ADVISORS LP (US$162.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARWR

All ARWR fund holders →

FAQ

How long has Evolutionary Tree Capital Management, LLC held ARWR?

Evolutionary Tree Capital Management, LLC has disclosed ARWR holdings in 5 of the last 13 reported quarters, going back to Q3 2023.

What is Evolutionary Tree Capital Management, LLC's current position in ARWR?

As of Q3 2026, Evolutionary Tree Capital Management, LLC holds 19.14K shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), valued at $1.25M, representing 2.32% of its reported portfolio and ranking #21.

Has Evolutionary Tree Capital Management, LLC been buying or selling ARWR?

In the latest 13F filing (Q3 2026), Evolutionary Tree Capital Management, LLC increased its position in ARWR. The position peaked in Q4 2023 at 51.69K shares.

Which other funds hold ARWR?

Other major institutional holders of ARWR include Avoro Capital Advisors LLC, FRED ALGER MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.